Release of cystic fibrosis airway inflammatory markers from pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4728-4738

  Yoo, Dae Goon ^a   Winn, Matthew ^a   Pang, Lan ^a   Moskowitz, Samuel M ^b,c   Malech, Harry L ^d   Leto, Thomas L ^d   Rada, Balázs ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LEUKOCYTE ELASTASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MYELOPEROXIDASE; PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CELL INTERACTION; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE MARKER; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG DISEASE; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP FORMATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CYSTIC FIBROSIS; DNA; FEMALE; HUMANS; INFLAMMATION; MALE; MAP KINASE SIGNALING SYSTEM; NADPH OXIDASE; NEUTROPHILS; PEROXIDASE; PSEUDOMONAS AERUGINOSA; SUPEROXIDES;

EID: 84901281887     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301589     Document Type: Article

References (58)

1. Kim Chiaw, P., P. D. Eckford, and C. E. Bear. 2011. Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy. Essays Biochem. 50: 233-248.
2. Ciofu, O., C. R. Hansen, and N. Høiby. 2013. Respiratory bacterial infections in cystic fibrosis. Curr. Opin. Pulm. Med. 19: 251-258.
3. Cohen, T. S., and A. Prince. 2012. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 18: 509-519.
4. Foweraker, J. 2009. Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br. Med. Bull. 89: 93-110.
5. West, S. E., L. Zeng, B. L. Lee, M. R. Kosorok, A. Laxova, M. J. Rock, M. J. Splaingard, and P. M. Farrell. 2002. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 287: 2958-2967.
6. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4: 35-51.
7. Ratjen, F. 2006. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis. Curr. Opin. Pulm. Med. 12: 428-432.
8. Gaspar, M. C., W. Couet, J. C. Olivier, A. A. Pais, and J. J. Sousa. 2013. Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review. Eur. J. Clin. Microbiol. Infect. Dis. 32: 1231-1252.
9. Pisi, G., and A. Chetta. 2009. Airway clearance therapy in cystic fibrosis patients. Acta Med. 80: 102-106.
10. Cohen-Cymberknoh, M., D. Shoseyov, and E. Kerem. 2011. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am. J. Respir. Crit. Care Med. 183: 1463-1471.
11. Accurso, F. J., S. M. Rowe, J. P. Clancy, M. P. Boyle, J. M. Dunitz, P. R. Durie, S. D. Sagel, D. B. Hornick, M. W. Konstan, S. H. Donaldson, et al. 2010. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N. Engl. J. Med. 363: 1991-2003.
12. Yu, H., B. Burton, C. J. Huang, J.Worley, D. Cao, J. P. Johnson, Jr., A. Urrutia, J. Joubran, S. Seepersaud, K. Sussky, et al. 2012. Ivacaftor potentiation of multiple CFTR channels with gating mutations. J. Cyst. Fibrosis 11: 237-245.
13. Ramsey, B. W., J. Davies, N. G. McElvaney, E. Tullis, S. C. Bell, P. Drevínek, M. Griese, E. F. McKone, C. E. Wainwright, M. W. Konstan, et al; VX08-770-102 Study Group. 2011. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N. Engl. J. Med. 365: 1663-1672.
14. Sagel, S. D., B. D. Wagner, M. M. Anthony, P. Emmett, and E. T. Zemanick. 2012. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 186: 857-865.
15. Mayer-Hamblett, N., M. L. Aitken, F. J. Accurso, R. A. Kronmal, M. W. Konstan, J. L. Burns, S. D. Sagel, and B. W. Ramsey. 2007. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 175: 822-828.
16. Kim, J. S., K. Okamoto, and B. K. Rubin. 2006. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis. Chest 129: 1148-1154.
17. Regelmann, W. E., C. M. Siefferman, J. M. Herron, G. R. Elliott, C. C. Clawson, and B. H. Gray. 1995. Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis. Pediatr. Pulmonol. 19: 1-9.
18. Garner, H. P., J. R. Phillips, J. G. Herron, S. J. Severson, C. E. Milla, and W. E. Regelmann. 2004. Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis. J. Lab. Clin. Med. 144: 127-133.
19. Brinkmann, V., U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D. S. Weiss, Y. Weinrauch, and A. Zychlinsky. 2004. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
20. Papayannopoulos, V., K. D. Metzler, A. Hakkim, and A. Zychlinsky. 2010. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191: 677-691.
21. Brinkmann, V., B. Laube, U. Abu Abed, C. Goosmann, and A. Zychlinsky. 2010. Neutrophil extracellular traps: how to generate and visualize them. J. Vis. Exp. (36): pii: 1724.
22. Carswell, F., D. W. Robinson, C. C. Ward, and M. R. Waterfield. 1984. Deoxyribonucleic acid output in the sputum from cystic fibrosis patients. Eur. J. Respir. Dis. 65: 53-57.
23. Manzenreiter, R., F. Kienberger, V. Marcos, K. Schilcher, W. D. Krautgartner, A. Obermayer, M. Huml, W. Stoiber, A. Hector, M. Griese, et al. 2012. Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. J. Cyst. Fibros. 11: 84-92.
24. Papayannopoulos, V., D. Staab, and A. Zychlinsky. 2011. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy. PLoS ONE 6: e28526.
25. Dubois, A. V., A. Gauthier, D. Bréa, F. Varaigne, P. Diot, F. Gauthier, and S. Attucci. 2012. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. Am. J. Respir. Cell Mol. Biol. 47: 80-86.
26. Hunter, R. C., V. Klepac-Ceraj, M. M. Lorenzi, H. Grotzinger, T. R. Martin, and D. K. Newman. 2012. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am. J. Respir. Cell Mol. Biol. 47: 738-745.
27. Young, R. L., K. C. Malcolm, J. E. Kret, S. M. Caceres, K. R. Poch, D. P. Nichols, J. L. Taylor-Cousar, M. T. Saavedra, S. H. Randell, M. L. Vasil, et al. 2011. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS ONE 6: e23637.
28. Rada, B., M. A. Jendrysik, L. Pang, C. P. Hayes, D. G. Yoo, J. J. Park, S. M. Moskowitz, H. L. Malech, and T. L. Leto. 2013. Pyocyanin-enhanced neutrophil extracellular trap formation requires the NADPH oxidase. PLoS ONE 8: e54205.
29. Wilson, R., D. A. Sykes, D. Watson, A. Rutman, G. W. Taylor, and P. J. Cole. 1988. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect. Immun. 56: 2515-2517.
30. Rada, B., and T. L. Leto. 2013. Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections. Trends Microbiol. 21: 73-81.
31. Williams, B. J., J. Dehnbostel, and T. S. Blackwell. 2010. Pseudomonas aeruginosa: host defence in lung diseases. Respirology 15: 1037-1056.
32. Pang, L., C. P. Hayes, K. Buac, D. G. Yoo, and B. Rada. 2013. Pseudogoutassociated inflammatory calcium pyrophosphate dihydrate microcrystals induce formation of neutrophil extracellular traps. J. Immunol. 190: 6488-6500.
33. Kuhns, D. B., W. G. Alvord, T. Heller, J. J. Feld, K. M. Pike, B. E. Marciano, G. Uzel, S. S. DeRavin, D. A. Priel, B. P. Soule, et al. 2010. Residual NADPH oxidase and survival in chronic granulomatous disease. N. Engl. J. Med. 363: 2600-2610.
34. Rada, B. K., M. Geiszt, K. Káldi, C. Timár, and E. Ligeti. 2004. Dual role of phagocytic NADPH oxidase in bacterial killing. Blood 104: 2947-2953.
35. Rohrbach, A. S., D. J. Slade, P. R. Thompson, and K. A. Mowen. 2012. Activation of PAD4 in NET formation. Front. Immunol. 3: 360.
36. Leshner, M., S. Wang, C. Lewis, H. Zheng, X. A. Chen, L. Santy, and Y. Wang. 2012. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular traplike structures. Front. Immunol. 3: 307.
37. Wang, Y., M. Li, S. Stadler, S. Correll, P. Li, D. Wang, R. Hayama, L. Leonelli, H. Han, S. A. Grigoryev, et al. 2009. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184: 205-213.
38. Sly, P. D., C. L. Gangell, L. Chen, R. S. Ware, S. Ranganathan, L. S. Mott, C. P. Murray, and S. M. Stick; AREST CF Investigators. 2013. Risk factors for bronchiectasis in children with cystic fibrosis. N. Engl. J. Med. 368: 1963-1970.
39. Almyroudis, N. G., M. J. Grimm, B. A. Davidson, M. Rohm, C. F. Urban, and B. H. Segal. 2013. NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury. Front. Immunol. 4:40.
40. Fuchs, T. A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y.Weinrauch, V. Brinkmann, and A. Zychlinsky. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176: 231-241.
41. Hakkim, A., T. A. Fuchs, N. E. Martinez, S. Hess, H. Prinz, A. Zychlinsky, and H. Waldmann. 2011. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat. Chem. Biol. 7: 75-77.
42. Keshari, R. S., A. Verma, M. K. Barthwal, and M. Dikshit. 2013. Reactive oxygen species-induced activation of ERK and p38 MAPK mediates PMA-induced NETs release from human neutrophils. J. Cell. Biochem. 114: 532-540.
43. Carlsson, M., L. Eriksson, I. Erwander, J. Wieslander, and M. Segelmark. 2003. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidalpermeability increasing protein (BPI)-autoantibodies. Clin. Exp. Rheumatol. 21 (6 Suppl. 32): S95-S100.
44. Parad, R. B., C. J. Gerard, D. Zurakowski, D. P. Nichols, and G. B. Pier. 1999. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect. Immun. 67: 4744-4750.
45. Emerson, J., M. Rosenfeld, S. McNamara, B. Ramsey, and R. L. Gibson. 2002. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr. Pulmonol. 34: 91-100.
46. Hodson, M. E. 1995. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis. Am. J. Respir. Crit. Care Med. 151: S70-S74.
47. Pilsczek, F. H., D. Salina, K. K. Poon, C. Fahey, B. G. Yipp, C. D. Sibley, S. M. Robbins, F. H. Green, M. G. Surette, M. Sugai, et al. 2010. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J. Immunol. 185: 7413-7425.
48. Akong-Moore, K., O. A. Chow, M. von Kölckritz-Blickwede, and V. Nizet. 2012. Influences of chloride and hypochlorite on neutrophil extracellular trap formation. PLoS ONE 7: e42984.
49. Parker, H., M. Dragunow, M. B. Hampton, A. J. Kettle, and C. C. Winterbourn. 2012. Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J. Leukoc. Biol. 92: 841-849.
50. Brinkmann, V., C. Goosmann, L. I. Kuhn, and A. Zychlinsky. 2012. Automatic quantification of in vitro NET formation. Front. Immunol. 3: 413.
51. Li, P., M. Li, M. R. Lindberg, M. J. Kennett, N. Xiong, and Y. Wang. 2010. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207: 1853-1862.
52. Parker, H., A. M. Albrett, A. J. Kettle, and C. C. Winterbourn. 2012. Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J. Leukoc. Biol. 91: 369-376.
53. Galli, F., A. Battistoni, R. Gambari, A. Pompella, A. Bragonzi, F. Pilolli, L. Iuliano, M. Piroddi, M. C. Dechecchi, and G. Cabrini; Working Group on Inflammation in Cystic Fibrosis. 2012. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim. Biophys. Acta 1822: 690-713.
54. Parker, H., and C. C. Winterbourn. 2012. Reactive oxidants and myeloperoxidase and their involvement in neutrophil extracellular traps. Front. Immunol. 3: 424.
55. Palmer, L. J., P. R. Cooper, M. R. Ling, H. J. Wright, A. Huissoon, and I. L. Chapple. 2012. Hypochlorous acid regulates neutrophil extracellular trap release in humans. Clin. Exp. Immunol. 167: 261-268.
56. Lu, T., S. D. Kobayashi, M. T. Quinn, and F. R. Deleo. 2012. A NET Outcome. Front. Immunol. 3: 365.
57. Metzler, K. D., T. A. Fuchs, W. M. Nauseef, D. Reumaux, J. Roesler, I. Schulze, V. Wahn, V. Papayannopoulos, and A. Zychlinsky. 2011. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117: 953-959.
58. Pereira, W. E., Y. Hoyano, R. E. Summons, V. A. Bacon, and A. M. Duffield. 1973. Chlorination studies. II. The reaction of aqueous hypochlorous acid with alpha-amino acids and dipeptides. Biochim. Biophys. Acta 313: 170-180.